增强人们的免疫系统是构建人类命运共同体的重要环节，为贯彻落实两会精神，立足新发展、新理念，构建新格局，推动形成以国内大循环为主体、国内国际双循环相互促进的新发展格局，为百姓提供更加优质的健康产品，在欧美同学会企业家联谊会的支持下，由协合生物集团、协合国际生物科技（广州）有限公司共同主办的协合超抗原支持国际免疫项目新闻发布会于2021年 4 月 8日下午在中国·北京中国大饭店举行。

来自医学界、企业代表等百余位嘉宾应邀出席了此次发布会。会议得到了中国健康产业投资基金、美国美中投资基金等单位的大力支持，并与人民日报网、光明网、中华网、中国网、中新网、腾讯网、澳门法制日报、地球村民网、新媒体头条等多家媒体共同见证了这一重要时刻。发布会的主题是“构筑人类免疫屏障、建设人类健康共同体”，参会人员共同聆听了生物学家和医学家对全球疫情形势、抗击疫情遇到的各种挑战、各种有效免疫举措及新冠病毒对人体免疫系统的伤害、新冠肺炎患者长期康复问题等与当下新冠疫情有关的见解。

如何通过提高免疫力打造长效免疫机制，更有效地应对当前的新冠疫情，能更好地帮助人类及时、有效对抗未来可能出现的病毒变异和新型致病微生物所导致的重大传染病危机是本次会议关注的焦点。    截至3月31日，全球感染新冠人数达到1.27亿，这场突如其来的传染病危机对世界经济和民生产生了前所未有的深重影响，促使人类必须深入思考，如何吸取此次防控传染病的经验和教训，从战略高度认识提高人类免疫力、打造人类健康的防火墙、有效应对未来可能出现的重大传染病疫情的重大意义。中国人民解放军技术一级教授、博士生导师 董宝玮教授总结，这次新冠疫情具有这样几个特点：爆发性发生、传播迅速、传播途径多样、病毒变异较快、破坏人体免疫系统、康复周期长、病情容易反复。

广东医学院公共卫生学院副院长、博士生导师石  明教授认为，提高免疫力是人类抗击类似传染病的真正防火墙。系统性地提高全人类的免疫力，有助于人类面对未来各种传染性疾病所带来的威胁。著名医学家董宝玮将军引述哈佛大学鲍威尔教授的观点“人类80%的疾病都和免疫系统的退化、低下有关，虽然各种疾病表面看来各不相同，但它们的康复过程却惊人的相似，均是免疫调整的结果”。公共卫生专家石明教授引述日本《免疫革命》的观点：“人类95%的疾病与免疫力低下有关，如果免疫力提高30%，各种肿瘤的发病率会降低50%，各种传染病的发病率降低50%，人体机能年轻10岁。” 

世界卫生组织的调查显示：人类中真正健康的人群只占5%，被诊断疾病的不足20%，其余75%以上的人都处在亚健康状态。而亚健康状态就是人体不同程度的免疫力低下状态。在这次新闻发布会上，协合生物集团的生物学家向全球介绍了一款中国原创的生物药品“协合超抗原产品金葡素注射液”和BM口服液。据协合的生物学家介绍，超抗原既是一种可以激活免疫细胞的物质，也是一种“超级”免疫现象，同时也是现代免疫学一个公认的理论。超抗原是一类能够高效激活免疫细胞、释放大量免疫因子从而激活人体免疫系统的物质，这类物质可以在极低的剂量下（以纳克为单位），在短时间内激活10-20%的T淋巴细胞、NK细胞、B细胞等免疫细胞，相比普通的抗原比如我们熟悉的灵芝、虫草、人参等，激活免疫细胞的效率高出2000-50000倍。金黄色葡萄球菌肠毒素蛋白质是公认的超抗原物质，而协合生物集团研发的金葡素注射液是目前全球唯一一个金黄色葡萄球菌来源的超抗原药品，其他国际同行因各种技术原因已经在4-7年前就终止了相关研究。据现场的医学家介绍，协合超抗原药品，可以明显提高CD3、CD4、CD8等T淋巴细胞的水平，还可以明显提高NK细胞的水平，可以促进包括白介素、肿瘤坏死因子、干扰素等免疫因子的释放，从而发挥抗肿瘤、抗病毒等防病抗病的作用。协合生物集团董事会主席陈巨余教授介绍说，协合超抗原药品在中国已经有20年的临床应用历史，在提高免疫力方面有确切可靠的临床证据，而且副作用很少，协合集团在既往的SARs、H1N1、MERs等传染病流行期间以及此次新冠流行期间均有大量的药品捐助，获得很好的反馈。尤其是口服制剂的研发，既可以发挥其超抗原超级免疫的功效，又可以避免出现免疫抑制，而且有利于大范围和长期使用。总之，提高免疫力，不仅仅有助于人体抗击各种致病微生物、抗击肿瘤等重大疾病威胁，还有助于病后的康复，有助于提高人类的生理机能！

协合国际生物科技（广州）有限公司董事长刘乐先生介绍说，协合广州公司的使命就是在全球发起和推动“全球免疫大联盟”，公司将与各国制药企业、研发机构、管理机构等通力合作，向全球推广改善免疫力的产品----超抗原，共同推进全球人类免疫事业，通过“全球免疫大联盟”，谋求全球人类健康福祉，特别是促进贫困地区人民提高健康水平。欧美同学会企业家联合会会长徐昌东先生介绍说，欧美同学会在全球有众多生物制药和医学界的优秀会员代表，欧美同学会企业家联谊会此次支持协合生物集团、协合国际生物科技（广州）有限公司，举办此次新闻发布会，就是要联合全球有识之士，共同构筑人类免疫屏障、打造免疫长效机制，以打造人类健康共同体的实际行动，响应党中央倡导的构建人类命运共同体的号召，将中国原创的免疫类生物药品推广向全世界，为支持全球抗击新冠疫情做出新贡献。

—————

中文资料提供：张蓉杰

图片摄影：韩好

编辑：成才、赵永光

编发：新媒体头条

—————

以下是汉译英内容报道

Theme: Building a human immune barrier and building a human health communityPurpose: Seeking the health and well-being of all man-kind.Press conference of the Global Immunization Alliancecontent:Enhancing people’s immune system is an important link in building a community with a shared future for mankind. In order to implement the spirit of the two sessions, deepen the study and publicity of General Secretary Xi Jinping’s important speech, build a new pattern based on new developments and new ideas, and promote the formation domestically. The new development pattern of mutual promotion of the international double cycle provides the people with better quality health products. With the support of the Western Returned Scholars Association Entrepreneur Alliance, co-sponsored by Xiehe Biological Group and Xiehe International Biotechnology (Guangzhou) Co., Ltd. The press conference of Concord Superantigen Support International Immunization Project will be held on the afternoon of April 8, 2021 at China World Hotel, in Beijing, China.More than a hundred guests from the medical profession and business representatives were invited to attend the conference. The meeting received strong support from China Health Industry Investment Fund, U.S.-China Capital INC. and other organizations, and jointly with People's Daily, Guangming.com, China.com, Chinanews.com, Tencent.com, Macau Legal Daily and many other media witnessed this important event.The theme of the press conference was "Building a human immune barrier and building a human health community". Participants listened to biologists and medical scientists on the global pandemic, various challenges in fighting the pandemic, and various effective immunization measures. Insights related to the current pandemic, such as the damage of the virus to the human immune system, the long-term recovery of patients with new strain of covid-19. Speaking upon how to build a long-term immune mechanism by improving immunity, more effectively respond to the current pandemic, and better helping everyone to fight in a timely and effective manner against major infectious disease crises caused by virus mutations and new pathogenic microorganisms that may appear in the future. The meeting focused on the mentioned topics above.    As of March 31, the number of people infected with Covid-19 reached 127 million globally. This sudden infectious disease crisis has had an unprecedented and profound impact on the world’s economy and people’s livelihoods, prompting humans to think deeply about how to learn from the experience of the prevention and control of infectious diseases. Lessons are learned from a strategic perspective of the significance of improving human immunity, building a firewall for human health, and effectively responding to major infectious diseases that may appear in the future.Professor Dong Baowei, a first-level professor of technology and a doctoral supervisor of the Chinese People’s Liberation Army, concluded that Covid-19 has the following characteristics: outbreak, rapid transmission, diverse transmission routes, rapid virus mutation, damage to the human immune system, and long recovery period, These conditions can recur often.From a long-term perspective, Professor Shi Ming, deputy dean and doctoral supervisor of the School of Public Health of Guangdong Medical College, believes that improving immunity is the real firewall for humans to fight similar infectious diseases. Systematically improving the immunity of all mankind will help mankind face the threats posed by various infectious diseases in the future.The famous medical scientist General Dong Baowei quoted the opinion of Professor Powell of Harvard University, “80% of human diseases are related to the degeneration and decline of the immune system. Although various diseases appear to be different on the surface, their recovery process is surprisingly similar. It is the result of immune adjustment".Professor Shi Ming, a public health expert, quoted the view of Japan’s "Immune Revolution": “95% of human diseases are related to low immunity. If immunity is increased by 30%, the incidence of various tumors will be reduced by 50%, and the incidence of various infectious diseases will be reduced by 50%. The incidence rate is reduced by 50%, and the human body function is technically 10 years younger."A survey by the World Health Organization shows that only 5% of humans are truly healthy, less than 20% of people have been diagnosed with diseases, and more than 75% of people are in sub-healthy conditions. The sub-health state is the state of low immunity of the human body to varying degrees.At this press conference, biologists from Xiehe Bio Group introduced an original Chinese biological drug "Xiehe Superantigen Product Aureus Staphyllin Injection" and BM oral liquid to the world.According to the biologists of Xiehe, superantigen is not only a substance that can activate immune cells, but also a kind of "super" immune phenomenon, and it is also a recognized theory in modern immunology. Superantigens are substances that can efficiently activate immune cells and release a large number of immune factors to activate the human immune system. Such substances can activate 10-20% in a short time at a very low dose (in nanograms). T lymphocytes, NK cells, B cells and other immune cells, compared with common antigens such as the familiar Ganoderma lucidum, Cordyceps, ginseng, etc., activate immune cells 2000-50000 times more efficiently.Staphylococcus aureus enterotoxin protein is recognized as a superantigenic substance, and staphylococcus aureus injection developed by Concord Biogroup is currently the only superantigen drug derived from Staphylococcus aureus in the world. Other international counterparts have already started related research four to seven years ago.According to on-site medical experts, Synergistic Superantigen drugs can significantly increase the level of T lymphocytes such as CD3, CD4, CD8, etc., and can also significantly increase the level of NK cells, and can promote immunity including interleukin, tumor necrosis factor, interferon, etc. The release of factors can play the role of anti-tumor, anti-virus and other disease prevention and disease resistance.Professor Chen Juyu, Chairman of the Board of Xiehe Biologics Group, said that Xiehe superantigen drugs have been used in China for 20 years. They have reliable clinical evidence for improving immunity and have few side effects. During SARs, H1N1, MERs and other infectious diseases and during the current pandemic, there were a large number of drug donations, and good feedback was obtained. In particular, the research and development of oral preparations can not only exert its super-antigen and super-immune effect, but also avoid immunosuppression, and is conducive to large-scale and long-term use. In short, improving immunity will not only help the human body fight against various pathogenic microorganisms, fight tumors and other major disease threats, but also help recover from illness and improve human physiology!Mr. Liu Le, chairman of Xiehe International Biotechnology (Guangzhou) Co., Ltd., said that Xiehe Guangzhou’s mission is to initiate and promote the “Global Immunization Alliance” internationally. The company will cooperate with pharmaceutical companies, R&D institutions, and management institutions in various countries. Work together to promote immunity-improving products-superantigens to the world, and jointly promote the global human immunization cause, through the "Global Immunization Alliance", to seek global human health and well-being, especially to promote the improvement of the health of people in poverty-stricken areas.Mr. Xu Changdong, President of the Western Returned Scholars Association Entrepreneur Alliance （WRSAEA）, said that the WRSAEA has many outstanding members in the biopharmaceutical and medical fields around the world. The WRSAEA supports Xiehe Biological Group and Xiehe International Biology. Science and Technology (Guangzhou) Co., Ltd. organized this press conference to unite people of insight around the world to jointly build a human immune barrier and build a long-term immune mechanism to build a human health community. This agenda responds to the actions of General Secretary Xi Jinping. The call to build a community with a shared future for mankind will promote China's original immunological biological drugs to the world, and contribute to supporting the global fight against Covid-19.